1-6 of 6
Jillian R. Gunther
Close
Sort by
Journal Articles

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R. Hwang, Arushi Khurana, Thomas M. Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S. Lossos, Kevin David, Andrew M. Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Ryan Lynch, Stephen Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Fang, Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun J. Lee
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7485–7493.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

SIRPα + macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

Mario L. Marques-Piubelli, Edwin R. Parra, Lei Feng, Luisa Solis Soto, Mariana Gallardo, Sushanth Gouni, Felipe Samaniego, Mansoor Noorani, Fredrick B. Hagemeister, Jason R. Westin, Hun Ju Lee, Maria A. Rodriguez, Sattva S. Neelapu, Jillian R. Gunther, Nathan H. Fowler, Christopher R. Flowers, Ignacio I. Wistuba, Loretta J. Nastoupil, Francisco Vega, Paolo Strati
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3286–3293.
https://doi.org/10.1182/bloodadvances.2022007104
Published: 2022
Includes: Supplemental data
Journal Articles

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha C. Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, M. Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2871–2883.
https://doi.org/10.1182/bloodadvances.2020001837
Published: 2020
Journal Articles

Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma

Clinical Trials & Observations
Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang, Bouthaina S. Dabaja
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2035–2039.
https://doi.org/10.1182/bloodadvances.2019030858
Published: 2019
Journal Articles

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Sarah A. Milgrom, Chan Yoon Cheah, Jillian R. Gunther, Ethan B. Ludmir, Christine F. Wogan, Loretta J. Nastoupil, Sattva S. Neelapu, Jason Westin, Hun J. Lee, Swaminathan P. Iyer, Raphael E. Steiner, Luis E. Fayad, Nathan H. Fowler, Michael L. Wang, Felipe Samaniego, Maria A. Rodriguez, Amy E. Rich, L. Jeffrey Medeiros, Bouthaina S. Dabaja
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1356–1367.
https://doi.org/10.1182/bloodadvances.2018029140
Published: 2019
Journal Articles

Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL

Clinical Trials & Observations
Chelsea C. Pinnix, Andrea K. Ng, Bouthaina S. Dabaja, Sarah A. Milgrom, Jillian R. Gunther, C. David Fuller, Grace L. Smith, Zeinab Abou Yehia, Wei Qiao, Christine F. Wogan, Mani Akhtari, Osama Mawlawi, L. Jeffrey Medeiros, Hubert H. Chuang, William Martin-Doyle, Philippe Armand, Ann S. LaCasce, Yasuhiro Oki, Michelle Fanale, Jason Westin, Sattva Neelapu, Loretta Nastoupil
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1334–1343.
https://doi.org/10.1182/bloodadvances.2018017681
Published: 2018